| 今开：116.12 | 昨收：116.81 |
| 最高：118.91 | 最低：115.075 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：7.323046689E9 |
蓝图医药(BPMC)05-07 05:25
$蓝图医药(BPMC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-012356 Size: 16 KB 网页链接查看全文
蓝图医药(BPMC)05-03 04:15
$蓝图医药(BPMC)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-003314 Act: 33 Size: 6 KB 网页链接查看全文
蓝图医药(BPMC)06-05 04:05
$蓝图医药(BPMC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015315 Size: 25 KB 网页链接查看全文
蓝图医药(BPMC)07-09 07:15
$蓝图医药(BPMC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-019391 Size: 4 KB 网页链接查看全文
蓝图医药(BPMC)07-09 04:15
$蓝图医药(BPMC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-019331 Size: 14 KB 网页链接查看全文
蓝图医药(BPMC)06-15 05:45
$蓝图医药(BPMC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-016983 Size: 7 KB 网页链接查看全文
蓝图医药(BPMC)06-22 04:45
$蓝图医药(BPMC)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001104659-24-073973 Act: 33 Size: 954 KB 网页链接查看全文
蓝图医药(BPMC)05-11 04:15
$蓝图医药(BPMC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-012843 Size: 18 KB 网页链接查看全文
蓝图医药(BPMC)05-18 04:15
$蓝图医药(BPMC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-013468 Size: 14 KB 网页链接查看全文
蓝图医药(BPMC)05-24 20:05
$蓝图医药(BPMC)$ 8-K Current report, item 8.01 Accession Number: 0001558370-24-008619 Act: 34 Size: 152 KB 网页链接查看全文
张小丰2018-11-28 22:49
$Loxo Oncology(LOXO)$ 今天被Loxo刷屏。。主要是很多人被标题党。这个靶向药针对一种罕见的基因突变。大致占比1%。然后在这1%中效果非常惊人。也就是一个罕见药。
很多人说今天是抗癌巨大的突破，实际上突破在1年半前的ASCO医疗峰会就知道了，那时候公布了非常强大的数据，基本上已经确定这药...查看全文
999875ass2018-11-07 00:03
最近微信朋友圈传的《我在美国治肺癌》详细的记录了一位老爷子从最初诊断到初见疗效的治疗过程。看完之后，不禁感慨，人世间千万般，同病不同命，在中国我们能做什么呢？
这篇读后感将详细分析这位老爷子的看病历程，并有相应的专业解读...查看全文
张小丰2018-11-04 23:42
回复@forcode: 已经成功一大半了。你去看一看2个最新做靶向药的小公司$Loxo Oncology, Inc. (LOXO)$ $Blueprint Medicines Corporation(BPMC)$ 这几年的股票回报率//@forcode:回复@Stevevai1983:这个公司的靶向药如果临床试验过关，是不是股价会一飞冲天？但是也可能失败查看全文
forcode2018-11-04 23:35
这个公司的靶向药如果临床试验过关，是不是股价会一飞冲天？但是也可能失败//@Stevevai1983:回复@杨天南财务健康谈:blu667是ret突变靶向药物，$Blueprint Medicines Corporation(BPMC)$ 公司的。牛逼炸天。如果没记错中国基石药业已经引进了。过几年中国患者有望用上。查看全文
张小丰2018-11-04 23:31
blu667是ret突变靶向药物，$Blueprint Medicines Corporation(BPMC)$ 公司的。牛逼炸天。如果没记错中国基石药业已经引进了。过几年中国患者有望用上。查看全文
淘沙见金2018-10-10 11:43
$Blueprint Medicines Corporation(BPMC)$ BPMC reported an updated ORR as well at ATA, which was 49%. Of course, LOXO appears better but the ORR are likely very similar. The ORR at the highest doses for BLU-667 was 62%, which might be the better comparison as all (or close to ...查看全文
淘沙见金2018-10-10 11:41
$Loxo Oncology, Inc. (LOXO)$ reported much better MTC RET altered data at ATA. They increased the ASCO reported response rate to 59% from 45%. This was the result of 7 additional responses of which 5 were from previously evaluated patients. This is an important caveat as the ...查看全文
蹊之美股生物医药2018-06-05 11:35
$Deciphera医药(DCPH)$
上图是DCPH$Deciphera医药(DCPH)$ 昨晚在ASCO公布的数据，非常的不错。在间质瘤指征上，2线用药的ORR为24%，DCR为80%（3个月）。而目前市场上的2线用药sunitinib的ORR为7%，DCR为60%，3线用药regorafenib的ORR为4.5%，DCR为53%。因此获批的可能大为增加。公司昨天大涨...查看全文
$蓝图医药(BPMC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-019390 Size: 4 KB 网页链接
$蓝图医药(BPMC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-019391 Size: 4 KB 网页链接
$蓝图医药(BPMC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-019331 Size: 14 KB 网页链接
$蓝图医药(BPMC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-018850 Size: 9 KB 网页链接
$蓝图医药(BPMC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-018118 Size: 27 KB 网页链接
$蓝图医药(BPMC)$ 144 Report of proposed sale of securities Accession Number: 0001968582-24-000545 Act: 33 Size: 9 KB 网页链接
$蓝图医药(BPMC)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001104659-24-073973 Act: 33 Size: 954 KB 网页链接
$蓝图医药(BPMC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-016982 Size: 7 KB 网页链接
$蓝图医药(BPMC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-016984 Size: 7 KB 网页链接
$蓝图医药(BPMC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-016983 Size: 7 KB 网页链接